Jonathan Ngau - LeMaitre Vascular Senior Technology

LeMaitre Vascular Management Efficiency

The company has return on total asset (ROA) of 0.0872 % which means that it generated a profit of $0.0872 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1334 %, meaning that it created $0.1334 on every $100 dollars invested by stockholders. LeMaitre Vascular's management efficiency ratios could be used to measure how well LeMaitre Vascular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.13 in 2024. Return On Capital Employed is likely to gain to 0.12 in 2024. At this time, LeMaitre Vascular's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 364.1 M in 2024, whereas Non Current Liabilities Other is likely to drop slightly above 1.5 M in 2024.

Similar Executives

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people. LeMaitre Vascular (LMAT) is traded on NASDAQ Exchange in USA. It is located in 63 Second Avenue, Burlington, MA, United States, 01803 and employs 614 people. LeMaitre Vascular is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

LeMaitre Vascular Leadership Team

LeMaitre Stock Performance Indicators

Additional Tools for LeMaitre Stock Analysis